🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Aptahem AB (APTA)

Spotlight
Currency in SEK
1.1900
-0.0900(-7.03%)
Closed
APTA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
Day's Range
1.13001.2800
52 wk Range
1.130014.0053
Key Statistics
Edit
Bid/Ask
1.135 / 1.18
Prev. Close
1.28
Open
1.28
Day's Range
1.13-1.28
52 wk Range
1.13-14.0053
Volume
43.18K
Average Volume (3m)
22.94K
1-Year Change
-85.67%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APTA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Aptahem AB Company Profile

Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal pharmaceutical candidate is Apta-1, which is in preclinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients. The company has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children’s Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

Compare APTA to Peers and Sector

Metrics to compare
APTA
Peers
Sector
Relationship
P/E Ratio
−0.7x−1.7x−0.7x
PEG Ratio
−0.01−0.020.00
Price/Book
0.1x2.5x2.6x
Price / LTM Sales
3.7x8.5x3.2x
Upside (Analyst Target)
-64.9%47.1%
Fair Value Upside
Unlock23.8%7.3%Unlock

FAQ

What Is the Aptahem AB (APTA) Stock Price Today?

The Aptahem AB stock price today is 1.19.

What Stock Exchange Does Aptahem AB Trade On?

Aptahem AB is listed and trades on the Spotlight stock exchange.

What Is the Stock Symbol for Aptahem AB?

The stock symbol for Aptahem AB is "APTA."

What Is the Aptahem AB Market Cap?

As of today, Aptahem AB market cap is 6.74M.

What is Aptahem AB Earnings Per Share?

The Aptahem AB EPS is -2.12.

From a Technical Analysis Perspective, Is APTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.